Unexplained weight loss (UWL), defined as a loss of more than 5% of body weight within six to twelve months without a clear cause, is a common yet challenging clinical scenario. It can be a harbinger of serious underlying diseases, making its evaluation crucial in clinical practice.
UWL can be attributed to a myriad of conditions. These include malignancies, gastrointestinal disorders, endocrine diseases, infections, and psychiatric illnesses. In some cases, medications or aging may also cause weight loss. However, in approximately 15-25% of cases, the cause remains elusive even after extensive investigation.
A systematic and comprehensive approach to evaluating UWL is essential. A detailed history and physical examination are the cornerstones of diagnosis, often providing clues to the underlying cause. Laboratory tests, imaging studies, and endoscopic procedures may be required based on clinical suspicion. A watchful waiting approach may be appropriate in some patients, given that the cause of UWL may become apparent over time.
While imaging is not routinely recommended in the evaluation of UWL, it may be beneficial in certain scenarios. For instance, CT scans can be useful in detecting occult malignancies or abdominal pathologies. However, the use of imaging should be guided by the patient's history and physical examination findings.
Management of UWL is primarily directed towards treating the underlying cause, if identified. In cases where no cause is found, symptomatic treatment and regular follow-up are essential. Nutritional support may be required in patients with significant weight loss.
In conclusion, evaluating UWL necessitates a comprehensive and systematic approach, with a focus on history taking, physical examination, and judicious use of investigations. While challenging, a meticulous approach can often yield the underlying cause, enabling targeted treatment and improving patient outcomes.
1.
Rural colon cancer patients face higher risks, but minimally invasive surgery could narrow gap
2.
Chemotherapy before surgery helps patients with nose and sinus cancer avoid debilitating eye and bone removal
3.
Laryngeal Transplant Helped a Cancer Patient Speak Again in Pioneering Study
4.
The amount of liver tissue removed during gallbladder surgery has no discernible impact on overall survival.
5.
Long-Acting Interferon Therapy Approved for ET
1.
Molecular Network Mapping in Hematologic Disease
2.
Metabolic Reprogramming of the Tumor Microenvironment: Mechanisms, Clinical Relevance, and Emerging Therapeutic Strategies
3.
Hematopoietic Stem Cell Clonal Dynamics Across the Lifespan
4.
Connected Hematology Laboratory Networks for Automated Cross-Institution Data Exchange
5.
Digital Oncology Ecosystems Integrating Longitudinal Patient Trajectories: Transforming Cancer Care through Data-Driven Innovation
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
2.
Common side effects of cancer treatment and how they are managed
3.
Clinical Excellence in Hematology
4.
Best Practices in Hematology
5.
Current Scenario of Blood Cancer- Further Discussion on Genomic Testing & Advancement in Diagnosis and Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation